Gilead Sciences, Inc. (NASDAQ: GILD), a research-based biopharmaceutical company, is focused on discovering, developing, and commercializing novel medicines to address unmet medical needs. The company’s aim is to improve the care of patients suffering from life-threatening diseases with every new discovery and experimental drug candidate. Primary areas of focus include: antivirals, cardiovascular conditions and respiratory diseases. For further information, visit the Company’s web site at www.gilead.com.
Gilead Sciences, Inc. (NASDAQ: GILD)
November 3, 2008 at 6:41am
Archives
Select A Month
